PharmD Info

A forum for Indian Pharmacy Professionals

Treatment Guidelines - Hospital Institutional Guidelines, Standard Treatment Guidelines, WHO Guidelines, Disease Treatment Guidelines and etc
  • User avatar
User avatar
By Admin
#1910
The emergence of resistance to drugs used to treat tuberculosis (TB), and particularly multidrug-resistant TB (MDR-TB), has become a significant public health problem in a number of countries and an obstacle to effective TB control. In India, the available information from the several drug resistance surveillance studies conducted in the past suggest that the rate of MDR-TB is relatively low in India.

However this translates into a large absolute number of cases and as yet the management of patients with MDR-TB is inadequate. Specific measures are being taken within the Revised National Tuberculosis Control Programme (RNTCP) to address the MDR-TB problem through appropriate management of patients and strategies to prevent the propagation and dissemination of MDR-TB.

Traditionally, DOTS-Plus refers to DOTS programmes that add components for MDR-TB diagnosis, management and treatment. These guidelines promote full integration of DOTS and DOTS-Plus activities under the RNTCP, so that patients with MDR-TB are both correctly identified and properly managed under the recommendations set out in this document.

Finally, the guideline introduces new standards for registering, monitoring and reporting outcomes of multidrug-resistant TB cases. This uniform information management system will allow systematic, consistent data collection and analysis which will facilitate appropriate supervision and monitoring of the DOTS Plus activities and will play an important role in shaping future policies and recommendations.
Attachments:
(573.47 KiB) Downloaded 124 times
Similar Topics
Topics Statistics Last post
FDA SUPAC- IR,MR and SS Guidelines
by Admin  - 05 Dec 2020, 16:51  - In: FDA Guidelines
0 Replies 
221 Views
by Admin
05 Dec 2020, 16:51
WHO - Drug Disposal Guidelines
by Admin  - 16 Oct 2019, 11:34  - In: Treatment Guidelines
0 Replies 
22224 Views
by Admin
16 Oct 2019, 11:34
FIP Guidelines for Pharmacist COVID-19
by Admin  - 27 Apr 2020, 14:59  - In: Treatment Guidelines
0 Replies 
1360 Views
by Admin
06 Dec 2020, 23:23
Patient Counselling Guidelines
by Admin  - 02 Dec 2016, 21:35  - In: Patient Education
0 Replies 
2553 Views
by Admin
02 Dec 2016, 21:35
0 Replies 
3901 Views
by Admin
17 Apr 2016, 11:40

ACPE - Accreditation Council for Pharmacy Educatio[…]

There are a lot of comments on continuing D Pharm[…]

Follow these procedures to get AIIMS Hospital Appo[…]

Overview of regulatory environment in the USA, Eur[…]

PharmD Info - Highlights